278 related articles for article (PubMed ID: 15613182)
1. Daily sumatriptan for detoxification from rebound.
Drucker P; Tepper S
Headache; 1998 Oct; 38(9):687-90. PubMed ID: 15613182
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
3. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
4. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
Miner JR; Smith SW; Moore J; Biros M
Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
11. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
12. Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
McCrory P; Heywood J; Ugoni A
Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342
[TBL] [Abstract][Full Text] [Related]
13. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
Zeeberg P; Olesen J; Jensen R
Cephalalgia; 2009 Feb; 29(2):214-20. PubMed ID: 18823364
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis.
Centonze V; Bassi A; Causarano V; Dalfino L; Cassiano MA; Centonze A; Fabbri L; Albano O
Funct Neurol; 2000; 15(3):167-70. PubMed ID: 11062845
[TBL] [Abstract][Full Text] [Related]
15. Individualizing treatment with verapamil for cluster headache patients.
Blau JN; Engel HO
Headache; 2004; 44(10):1013-8. PubMed ID: 15546265
[TBL] [Abstract][Full Text] [Related]
16. Similarities and differences between chronic migraine and episodic migraine.
Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache.
Moore KL; Noble SL
Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
20. Migraine days decline with duration of illness in adolescents with transformed migraine.
Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
